Malken Bayrakdarian

Malken is a seasoned pharmaceutical leader with extensive experience in preclinical research development and driving innovation, compliance, and growth through strategic leadership.  He has held senior roles at CROs, CDMOs and at AstraZeneca, contributing to the advancement of multiple drug candidates from target discovery through to Phase II clinical development. Currently, he serves as Vice President, Drug Discovery at Sygnature Discovery in North America. 

Malken earned his PhD in Synthetic Organic Chemistry from the University of Montreal.